AstraZeneca PLC (OTCMKTS:AZNCF) Short Interest Update

AstraZeneca PLC (OTCMKTS:AZNCF) was the target of a large increase in short interest in the month of October. As of October 31st, there was short interest totalling 42,200 shares, an increase of 13.7% from the October 15th total of 37,100 shares. Based on an average daily volume of 2,500 shares, the days-to-cover ratio is presently 16.9 days.

AstraZeneca Stock Down 1.8 %

OTCMKTS AZNCF opened at $127.96 on Friday. The company has a 50-day moving average price of $148.69 and a 200-day moving average price of $155.24. AstraZeneca has a 52 week low of $118.16 and a 52 week high of $175.00.

Institutional Trading of AstraZeneca

An institutional investor recently bought a new position in AstraZeneca stock. Kennedy Capital Management LLC acquired a new stake in shares of AstraZeneca PLC (OTCMKTS:AZNCF) in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund acquired 37,554 shares of the company’s stock, valued at approximately $5,068,000. 40.87% of the stock is owned by institutional investors and hedge funds.

AstraZeneca Company Profile

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology.